EVMT — Evome Medical Technologies Cashflow Statement
0.000.00%
- CA$0.42m
- CA$16.47m
- CA$62.63m
- 51
- 86
- 16
- 50
Annual cashflow statement for Evome Medical Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 February 28th | 2020 February 29th | R2021 February 28th | 2022 February 28th | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.761 | -2.34 | -2.67 | -4.37 | -15.6 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.158 | 0.865 | 0.422 | 0.146 | 13.1 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 4.35 | 1.29 | 1.27 | -0.206 | -0.925 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 4 | -0.128 | -0.975 | -3.7 | -0.919 |
Capital Expenditures | 0 | — | 0 | -0.055 | -0.203 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | -0.899 | 0.075 | -4.56 | -1.32 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 0 | -0.899 | 0.075 | -4.62 | -1.52 |
Financing Cash Flow Items | 0 | — | 0 | -0.66 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | — | 5.43 | 3.94 | 0.825 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3.25 | -0.954 | 4.16 | -4.45 | -1.01 |